Hess' track record for efficiently allocating capital and generating value has been steadily improving. The company has streamlined its portfolio by jettisoning less competitive and riskier positions ...
If the president thinks climate change is a hoax, he should try to read some of the reports from the overwhelming majority of climate scientists whose research indicates otherwise ...
Obesity-drug maker Metsera Inc.'s stock jumped 47% on Friday as the biggest gainer among three initial public offerings bucking a swoon in the equity market to rise in their stock-market debuts Friday ...